Abstract P5-16-08: Phase Ib/II Trial Evaluating Safety and Efficacy of Copanlisib (PI3K Inhibitor) and Trastuzumab in Pre-Treated Advanced HER2-positive Breast Cancer: Results from the PantHER Study
Cancer research(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined